A study of the efficacy of cervical ripening with nitric oxide donor versus placebo for cervical priming before second-trimester termination of pregnancy

Contraception

Volumn 68, Issue 4, 2003, Pages 269-272

  Li, Chiu fai Ivy ^a   Chan, Chi wai Carina ^a   Ho, Pak chung ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cervical priming; Nitric oxide donor; Second trimester induced abortion

Indexed keywords

ABORTIVE AGENT; ISOSORBIDE MONONITRATE; MISOPROSTOL; NITRIC OXIDE DONOR; PLACEBO; PROSTAGLANDIN;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; GESTATIONAL AGE; HEADACHE; HEART PALPITATION; HUMAN; INDUCED ABORTION; LABOR INDUCTION; NORMAL HUMAN; PREGNANCY TERMINATION; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SECOND TRIMESTER PREGNANCY; UTERINE CERVIX RIPENING;

EID: 0142157542     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-7824(03)00170-7     Document Type: Article

References (17)

1. Wong K.S., Ngai C., Wong A.Y.K., Tang L.C.H., Ho P.C. Vaginal misoprostol compared with vaginal gemeprost in termination of second trimester pregnancy. Contraception. 58:1998;207-210.
2. Ho P.C., Ngai S.W., Liu K.L., Wong C.Y.G., Lee W.H.S. Vaginal misoprostol compared with oral misoprostol in termination of second-trimester pregnancy. Obstet Gynecol. 90:1997;735-738.
3. Ho P.C., Tsang S.S., Ma H.K. Reducing the induction to abortion interval in termination of second trimester pregnancies a comparison of mifepristone with laminaria tent . Br J Obstet Gynaecol. 102:1995;648-651.
4. El Marandny E., Kanayama N., Halim A., Maehara K., Terao T. Biochemical changes in the cervical mucus after application of laminaria tent. Acta Obstet Gynecol Scand. 75:1996;203-207.
5. Anggard E. Nitric oxide mediator, murderer, and medicine . Lancet. 343:1994;1199-1206.
6. Ekerhovd E., Brannstrom M., Weijdegard B., Norstrom A. Nitric oxide synthases in the human cervix at term pregnancy and oxide on cervical smooth muscle contractility. Am J Obstet Gynecol. 183:2000;610-616.
7. Ekerhovd E., Brannstrom M., Weijdegard B., Norstrom A. Localization of nitric oxide synthase and effects of nitric oxide donors on the human Fallopian tube. Mol Hum Reprod. 5:1999;1040-1047.
8. Yallampalli C., Garfield R.E., Byam-Smith M. Nitric oxide inhibits uterine contractility during pregnancy but not during delivery. Endocrinology. 133:1993;1899-1902.
9. Romero R. Clinical application of nitric oxide donors and blockers. Hum Reprod. 13:1998;248-250.
10. Thomson A.J., Burnett C.L., Cameron I.T., Greer I.A., Norman J.E. Nitric oxide donors induce ripening of the human cervix a randomised controlled trial . Br J Obstet Gynaecol. 104:1997;1054-1057.
11. Thomson A.J., Lunan C.B., Ledingham M., et al. Randomised trial of nitric oxide donor versus prostaglandin for cervical ripening before first trimester termination of pregnancy. Lancet. 352:1998;1093-1096.
12. Chanrachakul B., Herabutya Y., Punyavachira P. Randomized comparison of glyceryl trinitrate and prostaglandin E2 for cervical ripening at term. Obstet Gynecol. 96:2000;549-553.
13. Luzi G., Caserta G., Iammarino G., Clerici G., Di Renzo G.C. Nitric oxide donors in pregnancy fetomaternal hemodynamic effects induced in mild pre-eclampsia and threatened preterm labor . Ultrasound Obstet Gynecol. 14:1999;101-109.
14. Nakatsuka M., Tada K., Kimura Y., et al. Clinical experience of long-term transdermal treatment with nitric oxide donor for women with preeclampsia. Gynecol Obstet Invest. 47:1999;13-19.
15. Meinert C.L. Clinical trials design, conduct and analysis . 1986;71-89 Oxford University Press, Oxford.
16. Ekerhovd E., Weidegard B., Brannstrom M., Norstrom A. Nitric oxide-mediated effects on myometrial contractility at term during prelabour and labour. Obstet Gynecol. 93:1999;987-994.
17. nd ed. 1999;1109-1112 Churchill Livingstone, Toronto.